0
Skip to Content
Can Med CA
Products
About
Contact
Can Med CA
Products
About
Contact
Products
About
Contact
All Products CERAMENT® G WITH GENTAMICIN
Screenshot+2025-05-13+at+4.08.59%E2%80%AFPM.jpg Image 1 of
Screenshot+2025-05-13+at+4.08.59%E2%80%AFPM.jpg
Screenshot+2025-05-13+at+4.08.59%E2%80%AFPM.jpg

CERAMENT® G WITH GENTAMICIN

$25.00

The first and only FDA authorized, injectable, broad spectrum antibiotic-eluting bone void filler.

CERAMENT G is an injectable synthetic bone void filler consisting of 40% hydroxyapatite, 60% calcium sulfate and the antibiotic gentamicin sulfate.

The characteristics of CERAMENT G mean that surgeons can manage bone defects in a more patient-friendly single-stage procedure. CERAMENT G has proven clinical outcomes, with one of the lowest (re)fracture and (re)infection rates of any synthetic bone substitute on the market. Moving to a single-stage from a multi-stage surgical protocol also frees healthcare resources to meet other needs, paving the way for a more cost-effective strategy for hospitals.

Add To Cart

The first and only FDA authorized, injectable, broad spectrum antibiotic-eluting bone void filler.

CERAMENT G is an injectable synthetic bone void filler consisting of 40% hydroxyapatite, 60% calcium sulfate and the antibiotic gentamicin sulfate.

The characteristics of CERAMENT G mean that surgeons can manage bone defects in a more patient-friendly single-stage procedure. CERAMENT G has proven clinical outcomes, with one of the lowest (re)fracture and (re)infection rates of any synthetic bone substitute on the market. Moving to a single-stage from a multi-stage surgical protocol also frees healthcare resources to meet other needs, paving the way for a more cost-effective strategy for hospitals.

The first and only FDA authorized, injectable, broad spectrum antibiotic-eluting bone void filler.

CERAMENT G is an injectable synthetic bone void filler consisting of 40% hydroxyapatite, 60% calcium sulfate and the antibiotic gentamicin sulfate.

The characteristics of CERAMENT G mean that surgeons can manage bone defects in a more patient-friendly single-stage procedure. CERAMENT G has proven clinical outcomes, with one of the lowest (re)fracture and (re)infection rates of any synthetic bone substitute on the market. Moving to a single-stage from a multi-stage surgical protocol also frees healthcare resources to meet other needs, paving the way for a more cost-effective strategy for hospitals.

Click to visit website

Can Med CA

LinkedIn

Contact

canmedca@canmedca.com
(805)-680-1614